Inhaled xenon modulates microglia and ameliorates disease in mouse models of amyloidosis and tauopathy

Wesley Nogueira Brandão(Brigham and Women's Hospital), Oleg Butovsky(Brigham and Women's Hospital), Kristen Pitts(Brigham and Women's Hospital), Hayk Davtyan(University of California, Irvine), Dilansu Güneykaya(Brigham and Women's Hospital), Tian Cao(Brigham and Women's Hospital), Eric Tycksen(Washington University in St. Louis), Jason D. Ulrich(Hope Center for Neurological Disorders), Nimansha Jain(Washington University in St. Louis), Mathew Blurton‐Jones(University of California, Irvine), Howard L. Weiner(Baylor College of Medicine), Javier Remolina Serrano(Hope Center for Neurological Disorders), Caroline Baufeld(Brigham and Women's Hospital), Kilian Kleemann(Brigham and Women's Hospital), Taha Yahya(Brigham and Women's Hospital), Rajesh Krishnan(Brigham and Women's Hospital), Neta Rosenzweig(Brigham and Women's Hospital), David M. Holtzman(Hope Center for Neurological Disorders), Michael Aronchik(Brigham and Women's Hospital), Xiaoming Zhang(Brigham and Women's Hospital), Xin Bao(Weihai Maternal and Child Health Hospital), Alexandra Litvinchuk(Hope Center for Neurological Disorders), Hong Jiang(Washington University in St. Louis), Ana Durao(Brigham and Women's Hospital), I I Il'in(Harvard Bioscience (United States)), Zhuoran Yin(Brigham and Women's Hospital), Jen‐Li Barry(Brigham and Women's Hospital), Madison Carpenter(Brigham and Women's Hospital)
Science Translational Medicine
January 15, 2025
Cited by 11


Related Papers